ym17e has been researched along with tyloxapol in 1 studies
| Studies (ym17e) | Trials (ym17e) | Recent Studies (post-2010) (ym17e) | Studies (tyloxapol) | Trials (tyloxapol) | Recent Studies (post-2010) (tyloxapol) |
|---|---|---|---|---|---|
| 10 | 1 | 0 | 414 | 1 | 84 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, K; Higuchi, S; Uchida, T; Watanabe, T | 1 |
1 other study(ies) available for ym17e and tyloxapol
| Article | Year |
|---|---|
Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
Topics: Animals; Anticholesteremic Agents; Biological Availability; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Data Interpretation, Statistical; Diet, Atherogenic; Digestive System; Digestive System Physiological Phenomena; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hyperlipidemias; Intestinal Absorption; Iodine Radioisotopes; Lipoproteins, LDL; Liver; Male; Metabolic Clearance Rate; Phenylurea Compounds; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Sterol O-Acyltransferase; Surface-Active Agents; Tissue Distribution | 1998 |